Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Function-Friendly Semi-Fowler Positioning for Coronary Angiography and PCI

torstai 12. marraskuuta 2026 päivittänyt: Shanghai Zhongshan Hospital

Pilot Study on the Feasibility and Safety of Function-Friendly Semi-Fowler Positioning in Coronary Angiography and Percutaneous Coronary Intervention

This study will assess whether planned coronary angiography (CAG), and simple percutaneous coronary intervention (PCI) when needed, can be completed safely and technically while participants are in a semi-sitting position with the head of the procedure table raised to 60 degrees. Ten clinically stable adults scheduled for an elective procedure are planned. The first stage will include participants undergoing CAG. After a safety review, the study may include participants expected to need only simple PCI. Heart rhythm, blood pressure, and blood oxygen will be monitored continuously. If predefined safety criteria occur, staff will lower the table or return the participant to a flat position and provide usual clinical care. Researchers will describe procedure completion, image quality, radiation exposure, contrast use, tolerance of the position, and safety events through 3 days after the procedure. This exploratory study is not designed to establish treatment efficacy.

Tutkimuksen yleiskatsaus

Tila

Ei vielä rekrytointia

Ehdot

Interventio / Hoito

Yksityiskohtainen kuvaus

This is a prospective, single-center, open-label, single-arm, staged early-feasibility study at Zhongshan Hospital, Fudan University. The planned enrollment is 10 participants aged 18 to 75 years. Eligible participants are clinically stable and scheduled for elective transradial CAG or planned simple PCI, and can tolerate a monitored 60-degree semi-Fowler position for at least 10 minutes before the procedure. The first stage prioritizes CAG. Participants expected to need only simple PCI may be enrolled only after a safety review confirms that the workflow is executable without unacceptable risk. During CAG and, when clinically indicated, simple PCI, the procedure table will be raised to a default head elevation of 60 degrees. ECG, blood pressure, and oxygen saturation will be monitored continuously. If chest pain, significant dyspnea, persistent oxygen saturation below 90%, systolic blood pressure below 90 mmHg or a decrease of at least 30% requiring intervention, sustained ventricular tachycardia or fibrillation, cerebral hypoperfusion, equipment collision, catheter or tubing traction, or another predefined safety concern occurs, the positioning intervention will stop and the table will be lowered or the participant returned to 0-degree supine; usual clinical care will take priority. CAG and PCI technical success will be described among participants undergoing the respective procedure. Safety events will be collected from the start of the positioning intervention through 3 days after the procedure. Other measures include image quality, completion of standard projections, fluoroscopy time, dose-area product, contrast volume, procedure duration, positioning changes, and tolerance. No investigational drug is used. The commercial angiography X-ray system is used as a carrier for the positioning intervention; the study does not modify or evaluate the device.

Opintotyyppi

Interventio

Ilmoittautuminen (Arvioitu)

10

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskeluyhteys

Opiskelupaikat

      • Shanghai, Kiina
        • Zhongshan Hospital, Fudan University
        • Ottaa yhteyttä:

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

18 vuotta - 75 vuotta (Aikuinen, Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  1. Age 18 to 75 years.
  2. Clinically stable and scheduled for elective coronary angiography (CAG) or planned simple percutaneous coronary intervention (PCI), with no ongoing resting ischemia.
  3. Meets clinical indications for coronary angiography or intervention, with ischemic evidence consistent with coronary artery disease based on symptoms, ECG, or noninvasive imaging.
  4. Planned radial access; the operator expects the procedure can be performed using standard catheters and devices.
  5. Able to tolerate a monitored 60-degree semi-Fowler position for at least 10 minutes before the procedure.
  6. Body size, weight, shoulder width, and range of motion are within equipment and support-system limits, and the participant can be secured using the manufacturer-approved fixation system.
  7. Able to understand the study and provide written informed consent.

Exclusion Criteria:

  1. Pregnant or breastfeeding, or the participant or spouse plans pregnancy within the next 6 months.
  2. Known contraindication to local anesthetic or history of severe contrast-media allergy.
  3. Neurologic or psychiatric disease or language impairment that prevents effective communication or cooperation.
  4. Serious comorbidity with expected survival less than 6 months.
  5. Uncontrolled hypertension (screening systolic blood pressure >180 mmHg or diastolic blood pressure >100 mmHg) or baseline systolic blood pressure <100 mmHg.
  6. Acute coronary syndrome, ongoing ischemia, hemodynamic instability, cardiogenic shock, or need for emergency CAG/PCI.
  7. Decompensated heart failure, left ventricular ejection fraction <30%, inability to maintain oxygenation at rest, or estimated glomerular filtration rate <30 mL/min/1.73 m^2.
  8. Known or highly suspected high-risk left main disease, chronic total occlusion, complex bifurcation disease, severe calcification, or other anatomy expected to require complex PCI.
  9. Platelet count <50 × 10^9/L or coagulation results outside the institution usual acceptable range.
  10. Participation in another clinical trial or research study within 2 months before screening.
  11. Back pain, stiffness, limited mobility, or injury preventing tolerance of transition from supine to the study position.
  12. Inability to secure the torso reliably, inability to complete the pre-procedure positioning-tolerance test, or investigator judgment that emergency return to supine may be restricted.
  13. Any other condition for which the investigator considers participation unsafe.

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Muut
  • Jako: Ei käytössä
  • Inventiomalli: Yksittäinen ryhmätehtävä
  • Naamiointi: Ei mitään (avoin tarra)

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: Function-Friendly Semi-Fowler Positioning

All participants receive the same positioning intervention during elective transradial CAG and, if clinically indicated, simple PCI. The procedure table is raised to a default head elevation of 60 degrees, with continuous ECG, blood pressure, and oxygen saturation monitoring. If predefined safety concerns occur, the table angle is lowered or the participant is returned to 0-degree supine and usual clinical care is provided.

The procedure table head is elevated to a default 60-degree semi-Fowler position during elective transradial coronary angiography and, if clinically indicated, simple PCI. ECG, blood pressure, and oxygen saturation are continuously monitored. If predefined safety criteria occur, the table angle is reduced or the participant is immediately returned to 0-degree supine and usual clinical care is provided. The commercial angiography X-ray system and adjustable procedure table are used as available clinical equipment; no device hardware, software, collision protection, interlocks, image processing, or dose-control functions are modified or evaluated.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Proportion of Participants With Coronary Angiography (CAG) Technical Success
Aikaikkuna: During the CAG procedure

The number of participants undergoing CAG who complete the planned CAG in the prespecified semi-Fowler position without position-related unplanned return to supine or substantial angle reduction, procedure discontinuation, access-site change, missing key projections, or participant/equipment collision, and whose images are independently confirmed to be diagnostic, divided by the number of participants undergoing CAG.

During the CAG procedure
Proportion of Participants With Percutaneous Coronary Intervention (PCI) Technical Success
Aikaikkuna: During the PCI procedure

Among participants who undergo PCI, the proportion who complete planned device delivery, treatment, and withdrawal while meeting the protocol-defined positioning and safety requirements. PCI success is calculated using participants who undergo PCI as the denominator.

During the PCI procedure
Participants With Position-Related Serious Adverse Events or Prespecified Safety Events
Aikaikkuna: From the start of the positioning intervention through 3 days after the procedure

Number and proportion of participants experiencing a position-related serious adverse event or any prespecified safety event: hemodynamic instability, hypoxia, sustained arrhythmia, cerebral hypoperfusion, unplanned respiratory or circulatory support, mechanical collision, or emergency return to supine.

From the start of the positioning intervention through 3 days after the procedure

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Diagnostic Acceptability of Coronary Angiography Images
Aikaikkuna: During the procedure

Coronary angiography and fluoroscopy image quality rated on a 1-to-3 Likert scale; a score of 2 or 3 is acceptable. Images are assessed by two independent physicians, with adjudication by a third if needed.

During the procedure
Completion of Standard Coronary Angiographic Views and Visualization of Major Coronary Segments
Aikaikkuna: During the procedure

Completion of standard left anterior oblique, right anterior oblique, cranial, and caudal projections, and the ability to visualize the left anterior descending, left circumflex, and right coronary arteries and their major branches.

During the procedure
Total Fluoroscopy Time
Aikaikkuna: During the procedure

Total fluoroscopy time recorded during the CAG and, if performed, PCI procedure.

During the procedure
Dose-Area Product (DAP)
Aikaikkuna: During the procedure

Dose-area product and other radiation dose parameters recorded by the angiography system.

During the procedure
Contrast Volume
Aikaikkuna: During the procedure

Total contrast-media volume administered during the procedure.

During the procedure
Procedure Duration
Aikaikkuna: During the procedure

Total duration of the CAG procedure and, if performed, PCI procedure, recorded as specified in the study CRF.

During the procedure
Positioning Tolerance and Adjustments
Aikaikkuna: During the procedure

Table-head angle, number and reasons for position adjustments, participant symptoms, unplanned return to 0-degree supine, and equipment collision events.

During the procedure
Access and Device Delivery Completion
Aikaikkuna: During the procedure

Successful radial artery access and completion of planned device delivery and withdrawal, as applicable to the procedure performed.

During the procedure

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Sponsori

Tutkijat

  • Päätutkija: Junbo Ge, Fudan University

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Arvioitu)

Keskiviikko 25. marraskuuta 2026

Ensisijainen valmistuminen (Arvioitu)

Maanantai 1. toukokuuta 2028

Opintojen valmistuminen (Arvioitu)

Keskiviikko 1. marraskuuta 2028

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Torstai 12. marraskuuta 2026

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Torstai 12. marraskuuta 2026

Ensimmäinen Lähetetty (Todellinen)

Keskiviikko 18. marraskuuta 2026

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Keskiviikko 18. marraskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Torstai 12. marraskuuta 2026

Viimeksi vahvistettu

Sunnuntai 1. marraskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Muut tutkimustunnusnumerot

  • KY2026343

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

PÄÄTTÄMÄTÖN

IPD-suunnitelman kuvaus

The protocol states that any data sharing must use de-identified data and receive the required approvals. Whether individual participant data will be shared, and the timing, access process, and supporting information, have not yet been determined.

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .